HURTOWNIA FARMACEUTYCZNA SŁONECZNA KWIECIEŃ SPÓŁKA JAWNA

TAX ID9452218156

KRS0000769028

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. ŁĄKOWA 19, 31-443 KRAKÓW

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

HURTOWNIA FARMACEUTYCZNA SŁONECZNA KWIECIEŃ SPÓŁKA JAWNA

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. ŁĄKOWA 19, 31-443 KRAKÓW

Show on map

NIP

9452218156

REGON

369583659

KRS

0000769028

Legal form

general partnership

Register Address

UL. ŁĄKOWA 19, 31-443 KRAKÓW

Date of registration in KRS

2019-02-01

Date of commencement of economic activity

2019-02-01

Act signature

RDF/613220/24/857

Pkd codes

46.46.Z - Wholesale of pharmaceutical goods

32.99.Z - Other manufacturing notelsewhere classified

46.45.Z - Wholesale of perfume and cosmetics

46.90.Z - Non-specialised wholesale trade

47.79.Z - Retail sale of second-hand goods in specialised stores

68.20.Z - Rental and operating of own or leased real estate

73.20.Z - Market research and public opinion polling

81.22.Z - Specialised building and industrial cleaning activities

82.30.Z - Organisation of conventions and trade shows

82.99.Z - Other business support service activities not elsewhere classified

Payer VAT status

Active

Vat list bank account(s)

PL54 1050 1445 1000 0090 9563 4268

Company authorities

representation authorityREPRESENTING THE COMPANY PARTNERS

representation type

KAŻDY ZE WSPÓLNIKÓW UPRAWNIONY JEST DO SAMODZIELNEJ REPREZENTACJI SPÓŁKI.

REPRESENTING THE COMPANY PARTNERS

Gabriel Kwiecień

92 years old

Ewa Wardyńska Kępka

65 years old

shareholders

Gabriel Kwiecień

Ewa Wardyńska Kępka

proxies

Jakub Dudek

spontaneous prokura, 40 years old

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Profit (loss) on sale	0,8	1	-0,5	-154
Gross profit (loss)	1	1	-0,9	-194,3
EBITDA	1	1,1	-0,8	-173,4
Short time liabilities	14,6	19	22,5	18
Other operating costs	0,2	0,2	0,5	194,6
Equity capital	4,5	4,4	3,5	-20,6
Operating profit (EBIT)	1	1	-0,9	-188,7
Assets	19,1	23,4	26,1	11,3
Net profit (loss)	1	1	-0,9	-194,3
Cash	0,5	0,9	0,4	-51,3
Liabilities and provisions for liabilities	14,6	19	22,6	18,6
Net income from sale	72,6	95,9	117,7	22,7
Working assets	18,5	23,1	25,8	11,9
Other income costs	0,5	0,2	0,2	-17,3
Depreciation	0	0,1	0,1	-43,7
	%	%	%	p.p.
Profitability of capital	23,3	21,9	-26	-47,9
Equity capital to total assets	23,6	18,6	13,3	-5,3
Gross profit margin	1,4	1	-0,8	-1,8
EBITDA Margin	1,4	1,1	-0,7	-1,8
	Days	Days	Days	Days
Short term commitment turnover cycle	73	72	70	-2

Current financial liquidity indicator	1.2656160593032837	1.2127751111984253	1.1493701934814453	-0,1
Net dept to EBITDA	-0.4530324935913086	-0.8365336656570435	0.5553727746009827	1,4